An open access paper, fast-tracked in the journal AIDS, reviews seven studies that randomised almost 1300 participants to take ART only on 5, 4 or 3 days a week compared to daily dosing.
The results suggest that reduced dosing might safely become part of a crisis response to the changes in US international aid since 20 January. These changes already threaten ART for more than 20 million people living with HIV in low- and middle-income countries.
Read the full news story by Simon Collins, HIV i-Base here.
Simon Collins is a co-author on the paper in AIDS.
Source : HIV i-Base
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.